SKAN Research Trust and Quadram Institute Bioscience to collaborate in Gut Microbiome Research

SKAN Research Trust, promoted by Indian entrepreneur Mr. Ashok Soota and UK-based Quadram Institute Bioscience have entered into a Comprehensive Partnership Agreement to collaborate on research programmes focused on gut health and developing...

Granules India Net Profit Increases by 8.3% in Q4, dividend at 150%

Granules India, a Rs. 4,500 crore pharma major, has posted single digit growth in consolidated net profit during the fourth quarter ended March 2023 to Rs. 120 crore from Rs. 111 crore in the corresponding quarter of last year. Its revenues...

Hepion's NASH drug meets main goal of improving liver function in mid-stage trial

Hepion Pharmaceuticals Inc said yesterday its treatment met the main goal of improving liver function in patients with a type of fatty liver disease in a mid-stage study trial, sending its shares 45 per cent higher in premarket trading...

How Genetic Testing is Revolutionizing Personalized Medicine

Genetic testing allows doctors to tailor treatments to individual patients, making them more effective and reducing side effects. Genetic testing also enables doctors to provide more accurate diagnoses.

Amyris Signs Pact With Croda For Supply Of Sustainable Squalene

Amyris, Inc., a leading synthetic biotechnology company, announced that it has signed an exclusive licence agreement for the supply of sustainable squalene with British specialty chemicals company Croda International Plc (Croda)...

Genomics Market In India Expected To Grow At 18% Backed By Cost Effective Kits & Govt Initiatives: NRI Consulting

As per to leading consulting firm Nomura Research Institute (NRI) Consulting and Solutions India, the Indian genomic market in the country is expected to grow at 18% over the next five years, in tandem with the global genomics market growth....

IDMA strongly advises the NPPA to apply prospective batch pricing in order to reduce overcharging and ensure ease of doing business

The Indian Drug Manufacturers' Association (IDMA) has encouraged the National Pharmaceutical Pricing Authority (NPPA) to apply prospective batch pricing to eliminate overcharging and ensure business comfort...

How to Overcome Barriers to Entry in the Pharmaceutical Export Market

In businesses like the pharmaceutical industry, where producers make vast numbers of small items, economies of scale are crucial.

US FDA Approves Krystal Biotech's skin disorder gene therapy For Patients

The US Food and Drug Administration on Friday approved Krystal Biotech Inc's topical gene therapy for patients with a genetic skin disorder, making it the first-of-its kind treatment for epidermolysis bullosa. The therapy, Vyjuvek, has been...

Strides Pharma Science Receives an EIR from the US FDA for its Puducherry Facility

Strides Pharma Science Ltd announced this week that the US Food and Drug Administration (FDA) has issued an establishment inspection report (EIR) for its Puducherry manufacturing facility. The US Food and Drug Administration issues an EIR upon...

© 2024 India Pharma Outlook. All Rights Reserved.